Israel Maxx Abramowitz - Sep 14, 2021 Form 3/A - Amendment Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Not a 10% owner
Signature: /s/ Israel Maxx Abramowitz
Stock symbol: KTTA
Transactions as of: Sep 14, 2021
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 10/7/2021, 04:09 PM
Date Of Original Report: Sep 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KTTA	Common Stock						1.05M	Sep 14, 2021	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.

Content

This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.